Search research articles
Contact Us
Filters
Showing results (261-270 of 276) with videos related to
Page
of 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2022
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Patrizia Mondello, Jonas Paludo, Joseph P Novak, et al.
Cell Reports. Medicine
|
March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments
Jordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.
Biology Direct
|
September 9, 2006
Generalization of DNA microarray dispersion properties: microarray equivalent of t-distribution
Jaroslav P Novak, Seon-Young Kim, Jun Xu, et al.
Hematological Oncology
|
November 29, 2024
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance
Allison M Bock, Kerstin Wenzl, Joseph P Novak, et al.
Hematological Oncology
|
May 31, 2023
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas
Melissa A Hopper, Kerstin Wenzl, Keenan T Hartert, et al.
Frontiers in Aging Neuroscience
|
July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data
Isabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Blood Cancer Journal
|
July 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma
Janek S Walker, Kerstin Wenzl, Joseph P Novak, et al.
Blood Cancer Journal
|
October 9, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Melissa A Hopper, Abigail R Dropik, Janek S Walker, et al.
Nature Communications
|
August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 276) with videos related to
Sort By:
Page
of 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2022
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Patrizia Mondello, Jonas Paludo, Joseph P Novak, et al.
Cell Reports. Medicine
|
March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments
Jordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.
Biology Direct
|
September 9, 2006
Generalization of DNA microarray dispersion properties: microarray equivalent of t-distribution
Jaroslav P Novak, Seon-Young Kim, Jun Xu, et al.
Hematological Oncology
|
November 29, 2024
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance
Allison M Bock, Kerstin Wenzl, Joseph P Novak, et al.
Hematological Oncology
|
May 31, 2023
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas
Melissa A Hopper, Kerstin Wenzl, Keenan T Hartert, et al.
Frontiers in Aging Neuroscience
|
July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data
Isabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Blood Cancer Journal
|
July 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma
Janek S Walker, Kerstin Wenzl, Joseph P Novak, et al.
Blood Cancer Journal
|
October 9, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Melissa A Hopper, Abigail R Dropik, Janek S Walker, et al.
Nature Communications
|
August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Page
of 28